| Financial Year |
March 31 2023 |
| Monetary Funds |
546,352,847.26 |
| Held-for-trading Financial Assets |
539,806,295.92 |
| Notes Receivable |
36,837,542.02 |
| Accounts Receivable |
2,621,846,938.81 |
| Advances to Suppliers |
114,291,233.47 |
| Other Receivables |
141,392,425.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,534,107,896.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,613,282.47 |
| Total Current Assets |
8,553,568,447.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
122,855,385.12 |
| Long-term Equity Investment |
135,746,021.70 |
| Investment Properties |
12,794,412.96 |
| Fixed Assetes |
390,469,643.78 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
145,136,766.72 |
| R&D expenses |
63,086,765.44 |
| Goodwill |
1,505,197,394.63 |
| Long-Term Deferred and Prepaid Expenses |
8,660,306.34 |
| Deferred Income Tax Assets |
212,527,982.53 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,662,020,288.88 |
| Total Assets |
11,215,588,736.17 |
| Short-Term Loans |
169,722,104.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
783,674,247.83 |
| Accounts Payable |
1,866,466,253.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
465,188,156.22 |
| Taxes Payable |
80,510,606.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
126,139,542.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,668,518.92 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,875,497,241.85 |
| Long-term Loans |
66,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,731,746.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
144,883,870.63 |
| Total Liabilities |
5,020,381,112.48 |
| Paid-In Capital(Or Share Stock) |
983,653,713.00 |
| Capital Surplus |
2,478,603,057.54 |
| Surplus Reserve |
43,095,208.25 |
| LESS:Treasury Stock |
232,575,573.24 |
| Undistributed Profits |
2,753,621,137.35 |
| Minority Stockholder's Interest |
105,467,055.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,089,740,568.39 |
| Owner's Equity（Stockholder's Equity） |
6,195,207,623.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,215,588,736.17 |
